Strategic Intelligence: Genomics (2025)
Summary
Genomics refers to the study of an entire set of DNA within an organism. This includes researching their molecular components, structures and functions of genes, and developing technologies that map and edit sequences of DNA. There are many facets to the genomics market, like direct-to-consumer genetic (DTC-GT), prenatal screening, carrier, cancer, human leukocyte antigen (HLA) typing, and rare disease testing.
DTC-GT had been a rapidly expanding market that generated substantial amounts of revenue and public interest. DTC-GT is one format a person can get genetic testing through, the other option is through a healthcare provider. Thus, test types like genetic risk and carrier screening can be seen in both test formats. However, some of these DTC-GT tests can tell you if you have genetic markers for certain cancers or diseases. It has gained public scrutiny over privacy concerns over the service providers' handling of consumers’ genomic data. For instance, in 2023, there was a huge security breach of seven million people by 23andMe. Although this market had grown remarkably in earlier years, a slower growth rate in the past couple of years suggests the market has approached saturation, with continued declining future usage.
Scope
- Alcohol consumption is one of the first focal points for changed behavior when consumers seek to pursue healthier lifestyles.
- Half of drinkers globally state they are often or always influenced in their product choice by how an alcoholic beverage impacts their health and wellbeing.
- More than two thirds of alcohol consumers find products that have been fortified with added nutrients to be somewhat or very appealing.
- Understand and identify the better for you alcohol drinks innovation trend that consumers are interested in.
- Identify the specific aspects of healthiness that will appeal to consumers in the sector.
- Access valuable strategic take-outs in the form of specific opportunities to enhance future decision-making and inform new product development.
- Executive Summary
- Players
- Technology Briefing
- Next generation sequencing
- Sanger sequencing
- Polymerase chain reaction
- SNP-BeadArray chip technology
- Trends
- Technology trends
- Macroeconomic trends
- Regulatory trends
- Industry Analysis
- Direct-to-consumer genetic testing
- Genetic health risk tests
- Carrier screening tests
- Traits and wellness tests
- Ancestry tests
- Cancer biomarker testing
- Rare disease testing
- Non-invasive prenatal testing
- Human leukocyte antigen type testing
- Third-party data re-analysis
- Timeline
- Signals
- M&A trends
- Venture financing trends
- Patent trends
- Hiring trends
- Value Chain
- Technology
- DNA collection tubes
- Next generation sequencing
- SNP-BeadArray chips
- Sanger sequencing
- Polymerase chain reaction
- Genetic tests
- Genetic health risk tests
- Carrier screening tests
- Traits and wellness tests
- Ancestry tests
- Cancer biomarker tests
- Rare disease tests
- Non-invasive prenatal screening tests
- Human leukocyte antigen typing tests
- Third-party data re-analysis
- Commercial products
- Educational and research purposes
- Data storage
- Companies
- Public companies
- Private companies
- Sector Scorecard
- Medical devices sector scorecard
- Who’s who
- Thematic screen
- Valuation screen
- Risk screen
- Further Reading
- GlobalData reports
- Our Thematic Research Methodology
- About GlobalData
- Contact Us
- List of Tables
- Table 1: Technology trends
- Table 2: Macroeconomic trends
- Table 3: Regulatory trends
- Table 4: M&A trends
- Table 5: Venture financing trends
- Table 6: Public companies
- Table 7: Private companies
- Table 8: GlobalData reports
- List of Figures
- Figure 1: Who are the leading players in the genomics theme, and where do they sit in the value chain?
- Figure 2: Short vs. long-read NGS
- Figure 3: Different NGS read styles
- Figure 4: Sanger sequencing technique
- Figure 5: Illumina dominates the market for SNP-BeadArray chip technology
- Figure 6: Genetic testing has six market segments
- Figure 7: The genomics story
- Figure 8: Venture financing has been decreasing substantially in genomics since 2020
- Figure 9: The highest publication numbers were recorded in 2021
- Figure 10: Word map of skills required for genomics jobs shows soft skills are most sought after
- Figure 11: The genomics value chain
- Figure 12: The genomics technology value chain
- Figure 13: The genomics genetic tests value chain
- Figure 14: he genomics third-party data re-analysis value chain
- Figure 15: Who does what in the medical devices space?
- Figure 16: Thematic screen
- Figure 17: Valuation screen
- Figure 18: Risk screen
- Figure 19: Our five-step approach for generating a sector scorecard
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook